Kathy LaPorte

Kathy LaPorte

Director/Board Member en PRECIPIO, INC. .

Fortuna: 92 194 $ al 31/03/2024

62 años
Health Technology
Finance
Health Services

Perfil

Kathy D.
LaPorte
was the founder of New Leaf Venture Partners LLC, which was founded in 2005.
She held the title of Partner at the firm.
Ms. LaPorte is also the founder of HealthTech Capital Co. Ms. LaPorte's current job(s) include being a Director at Aesthetic Sciences Corp., Precipio Diagnostics LLC, Bolt Biotherapeutics, Inc., Precipio, Inc., Elysium Therapeutics, Inc., 89bio, Inc., Q32 Bio, Inc. (Massachusetts), D2G Oncology, Inc., and CERo Therapeutics Holdings, Inc. She is also a Director at Q32 Bio, Inc.Ms. LaPorte's former job(s) include being the Chief Executive Officer at Nodality, Inc. from 2015 to 2016.
She was also a Director at Cytyc Prenatal Products Corp., Onyx Pharmaceuticals, Inc., ISTA Pharmaceuticals, Inc., VNUS Medical Technologies, Inc., Transcept Pharmaceuticals, Inc. (Old), eHealth, Inc., Affymax, Inc., Cellgate, Inc., Prometheus Laboratories, Inc., eHealthInsurance Services, Inc., California Institute for Regenerative Medicine, Pearl Therapeutics, Inc., Transcept Pharma, Inc., Phoenix Biotech Acquisition Corp., and First Boston Corp.
She was a General Partner at Sprout Group from 1993 to 2004 and a Principal at Asset Management Co. from 1987 to 1992.
She was also a Partner at New Leaf Venture Partners LLC from 2005 to 2011 and a General Partner at Credit Suisse Securities (USA) LLC in 2005.
Additionally, she served as the President of the Western Association of Venture Capitalists.
Ms. LaPorte's education includes an undergraduate degree from Yale University in 1983 and an MBA from Stanford Graduate School of Business in 1987.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
15/04/2024 10 071 ( 0.71% ) 67 476 $ 31/03/2024
0.04%
05/04/2024 5 828 ( 0.04% ) 17 892 $ 31/03/2024
0.00%
25/03/2024 302 ( 0.00% ) 5 146 $ 31/03/2024
12/06/2023 1 200 ( 0.00% ) 1 680 $ 31/03/2024
01/02/2024 0 ( -.--% ) - $ 31/03/2024

Cargos activos de Kathy LaPorte

EmpresasCargoInicio
PRECIPIO, INC. Director/Board Member 09/08/2018
BOLT BIOTHERAPEUTICS, INC. Director/Board Member 01/12/2020
89BIO, INC. Director/Board Member 01/11/2021
Director/Board Member 01/08/2016
Director/Board Member 01/01/2020
Director/Board Member 03/08/2021
Director/Board Member -
Director/Board Member -
Todos los cargos activos de Kathy LaPorte

Antiguos cargos conocidos de Kathy LaPorte.

EmpresasCargoFin
California Institute for Regenerative Medicine Director/Board Member 01/09/2017
░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Kathy LaPorte.

Formación de Kathy LaPorte.

Yale University Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kathy LaPorte.

Relaciones

100 +

Relaciones de 1er grado

32

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas4
EHEALTH, INC.

Finance

AFFYMAX, INC.

Health Technology

PRECIPIO, INC.

Health Services

89BIO, INC.

Health Technology

Empresas privadas26
First Boston Corp.

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Finance

Health Technology

Finance

Health Technology

Finance

Finance

Finance

California Institute for Regenerative Medicine

Government

Western Association of Venture Capitalists

Health Technology

Health Technology

Finance

Bolt Biotherapeutics, Inc.

Health Technology

Health Technology

Health Technology

Finance

Ver las conexiones de la empresa